Patient Financial News

X-ray detectors are made of heavy, rigid materials such as silicon or germanium. The new flexible X-ray detectors are cheaper and can be shaped around the objects that need to be scanned, improving accuracy when screening patients and reducing risk when imaging tumours and administering radiotherapy, the study published in the journal Advanced Science said. «This new material is flexible, low-cost, and sensitive. But what's exciting is that this material is tissue equivalent.

India, November 3, 2023: Total Emergency Network (TEN), a pioneering startup that has disrupted the healthcare industry with its innovative approach to ambulance services, has successfully secured substantial funding of INR 1.5 Crore in its angel funding round. This crucial investment was led by BMV.Money (unstoppable start-up funding) and a group of dedicated family and friends.

A prominent cardiologist, Dr. Eva Lonn, at McMaster University in Hamilton, Ont. is under review by the university for comments made on social media about pro-Palestinian protests, calling for rallygoers to be deported.

Veterinarians in Canada say they are experiencing extreme burnout and plummeting mental health due to staff shortages, a booming number of animal patients and the round-the-clock stress of the job.

₹50 crore in revenue. In its qualified opinion on Pristyn Care’s internal controls, the auditor noted material weaknesses related to three areas: pricing for hospitals and patients, agreements with doctors and the vendor selection process.

Congress president Mallikarjun Kharge on Sunday appealed to people in Mizoram to vote for his party, saying while the Congress had helped bring peace and stability in the state, the BJP and the RSS were «hell-bent on destroying» Mizo culture and way of life. The Congress stands for the protection of the northeastern state's people, land and natural resources as enshrined under Article 371-G of the Constitution, he asserted ahead of the November 7 assembly polls.

Guardian reporter in Rafah which is on the southern end of the strip, witnessed many men from all ages entering Gaza through the Karem Abu Salem crossing between Israel and southern Gaza, which is normally only used for goods. As per the Guardian report, these men walked around 2 kilometres from the Israeli side of the border and had no phones, money, or even identity cards. Over 3,200 people were allegedly sent back via the joint Israeli-Egyptian checkpoint, according to a report published by the independent Egyptian news outlet Mada Masr.

Elon Musk, during a conversation with UK Prime Minister Rishi Sunak at an AI summit in London, made a prediction that artificial intelligence (AI) could render traditional paid work obsolete, the BBC reported. The 50-minute interview covered various aspects of AI, including the potential for humanoid robots capable of chasing "you anywhere". Musk and Sunak acknowledged London's prominence as a hub for the AI industry and discussed how AI could revolutionise education.

A cooling job market gives the Federal Reserve room to keep interest rates on hold in December and reinforces market views that the central bank is done with the most aggressive hiking campaign in four decades.

Zydus Lifesciences and Lupin on Friday announced signing of licensing and supply agreement to market Zydus' novel drug Saroglitazar Mg for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steato Hepatitis (NASH) in India. Under the terms of this agreement, Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS. Zydus launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them. Lupin will pay Zydus upfront licensing fees and milestone payments based on the achievement of pre-defined milestones. With a once-daily, 4mg dose regimen, Saroglitazar Mg enables better compliance, reduces pill burden, and offers greater convenience for patients. «Saroglitazar Mg which is one of the critical treatments for patients with NAFLD and NASH has substantially improved the patients’ quality of life. We are pleased to join hands with Lupin to enable access to this novel drug and thereby expand the reach,» said Dr.

Zydus Lifesciences Limited on Friday announced that they have entered into a licensing and supply agreement to co-market, Saroglitazar Mg for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steato Hepatitis (NASH) in India.

Delhi, NCR Pollution LIVE updates Dr Gupta suggested Delhi residents avoid going out early in the morning or late in the evening because the pollution level at that time is very high. Also read: Delhi-NCR air quality in 'severe' category for second day| Pics, videos "Nowadays every road is like a smoking zone. It not only affects patients who are allergic or have asthma but also normal people," the doctor added.

ANI reported. The order further read that individuals, groups or entities found to be in violation of this order shall be penalised in accordance with the relevant provisions of the law.

The tsunami-damaged Fukushima Daiichi nuclear power plant began its third release of treated and diluted radioactive wastewater into the sea after Japanese officials said the two earlier releases ended smoothly

patience is frequently overlooked. Yet, from a spiritual perspective, patience is not merely a virtue; it is a transformative force that leads to inner growth and fulfilment.

how to cut the sources that cause pollution," Rai told ANI on Thursday. The Commission for Air Quality Management meanwhile expect the pollution level to continue increasing in the upcoming days.

Dr Lal PathLabs on Thursday reported a 53% year-on-year (YoY) jump in net profit to Rs 111 crore in the second quarter ended September 30, 2023, led by improved volumes and measured price increases of diagnostic tests. Dr Lal PathLabs reported a Rs 72 crore net profit during the corresponding period of the previous year. Revenues rose 12.6% to Rs 601 crore in Q2FY24, compared to Rs 534 crore in Q2FY23. Earnings before interest, tax, depreciation, ammortisation (EBITDA) rose 23.6% YoY to Rs 178 crore. The EBITDA margins improved 270 basis points YoY to 29.6%. As on March 31, 2023 the company has 277 clinical laboratories, 5,102 Patient Service Centers (PSCs) and 10,938 Pick-up Points (PUPs). “We are seeing a healthy and steady rise in DLPL’s revenue growth trends both in value and volume terms.

(Reuters) -Eli Lilly on Thursday cut its annual profit outlook on charges related to recent acquisitions, and beat quarterly sales estimates driven by strong demand for its new blockbuster diabetes drug, Mounjaro.

Israel's ground troops advanced toward Gaza City on Thursday, as the US and Arab countries intensified diplomatic efforts to ease the siege of the Hamas-ruled enclave and bring about at least a brief stop to the fighting to help civilians. More than 9,000 Palestinians have been killed since the war broke out, health officials said. President Joe Biden suggested a humanitarian «pause» the day before, as an apparent agreement among the US, Egypt, Israel and Qatar, which mediates with Hamas, allowed hundreds of Palestinians with foreign passports and dozens of wounded to leave Gaza for the first time.

Never neglect any problem they cause. Whether it’s something as mundane as itching or something more alarming as pain or a prominent lump, ignoring any discomfort pertaining to your breasts may lead to irreversible health problems. Once thought to be an ‘older woman’s disease’, breast cancer is increasingly becoming frighteningly common among young women- below 40.

By Jacob Gronholt-Pedersen